Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02744768 |
|---|---|
| Brief Title: | D-ALBA Frontline Sequential Dasatinib and Blinatumomab in Adult Philadelphia Positive Acute Lymphoblastic Leukemia |
| First Submitted : | April 11, 2016 |
| First Submitted that Met QC Criteria : | April 18, 2016 |
| First Posted : | April 20, 2016 (Estimate) |
| Last Update Submitted that Met QC Criteria : | March 21, 2018 |
| Last Update Posted : | March 22, 2018 |